KIDNEY PATHOLOGY
DOI:
https://doi.org/10.30890/2709-2313.2022-15-01-011Keywords:
kidney tumors, clinical picture of kidney tumors, WHO 2016, malignancy grade, cancer with translocationAbstract
The article discusses the prevalence of kidney cancer and the problems of diagnosing this disease using radiological research methods. A comparative analysis of the effectiveness of various radiological methods in the diagnosis of kidney cancer is carriedMetrics
References
EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen 2018. ISBN 978-94-92671-01-1 EAU Guidelines Offi ce, Arnhem, Th e Netherlands. http://uroweb.org/guidelines/compilations-of-all-guidelines/
Wilson FP, Berns JS. Tumor Lysis Syndrome: New Challenges and Recent Advances. Adv Chronic Kidney Dis 2014;21(1):16-26. https://doi.org/10.1053/j.ackd.2013.07.001
Luciano RL, Brewster UC. Kidney Involvement in Leukemia and Lymphoma. Adv Chronic Kidney Dis 2014;21(1):27-35. https://doi.org/10.1053/j.ackd.2013.07.004
Jhaveri KD, Shah HH, Patel C et al. Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation. Adv Chronic Kidney Dis 2014;21(1): 48-55. https://doi.org/10.1053/j.ackd.2013.08.003
Perazella MA, Berns JS, Rosner MH. Cancer and the Kidney: The Growth of Onco- nephrology. Adv Chronic Kidney Dis 2014;21(1):4-6. https://doi.org/10.1053/j.ackd.2013.09.002
Shirali AC, Perazella MA. Tubulointerstitial Injury Associated With Chemotherapeutic Agents. Adv Chronic Kidney Dis 2014; 21(1):56-63. https://doi.org/10.1053/j.ackd.2013.06.010
Akilesh S, Juaire N, Duffield JS. et al Chronic Ifosfamide Toxicity: Kidney Pathology and Pathophysiology. Am J Kidney Dis 2014; 63(5):843-850. https://doi.org/10.1053/j.ajkd.2013.11.028
Campbell GA, Hu D, Okusa MD. Acute Kidney Injury in the Cancer Patient. Adv Chronic Kidney Dis 2014;21(1):64-71. https://doi.org/10.1053/j.ackd.2013.08.002
Lameire N. Nephrotoxicity of recent anti-cancer agents. Clin Kidney J 2014;7:11-12. https://doi.org/10.1093/ckj/sft135
Zupancic M, Shah PC, Shah-Khan F. Gemcitabineassociated thrombotic thrombocytopenic purpura. Lancet Oncol 2007; 8:634-641. https://doi.org/10.1038/cddis.2017.552
Ahn MJ, D’Cruz A, Vermorken JB et al. Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review. Oral Oncol 2016;53:10-16. https://doi.org/10.1016/j.oraloncology.2015.11.019
Martinez-Castelao A, Gorriz JL, Bover J et al. Consensus document for the detection and management of chronic kidney disease. Nefrologia 2014;34(2):243-262. https://doi.org/10.3265/Nefrologia.pre2014.Feb.12455
Aapro M, Launay-Vacher V. Importance of monitoring renal function in patients with cancer. Cancer Treat Rev 2012;38:235-240. https://doi.org/10.1016/j.ctrv.2011.05.001
Finkel M, Goldstein A, Steinberg Y et al. Cisplatinum nephrotoxicity in oncology therapeutics: retrospective review of patients treated between 2005 and 2012. Pediatr Nephrol 2014;29:2421-2424. https://doi.org/10.1007/s00467-014-2935-z
Damiano S, Ciarcia R, Montagnaro S et al. Prevention of Nephrotoxicity Induced by Cyclosporine-A: Role of Antioxidants. J Cell Biochem 2015;116:364-369. https://doi.org/10.1002/jcb.25022
M a T, Huang C, Xu Q et al. Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury. Cell Death Dis 2017;8(10):31-39
Kumar P, Barua CC, Sulakhiya K et al. Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy. Front Pharmacol 2017;8:1-32
A Double Blind, Placebo Controlled Dose Range Finding Study to Assess the Safety, Pharmacokinetics, and Efficacy of Tempol for the Reduction of Severe Mucositis in Head and Neck Cancer Patients Undergoing Combined Radio- and Chemotherapy. ClinicalTrials. gov Identifier: NCT03480971 First Posted: March 29, 2018
Skinner R, Kaplan R, Nathan PC. Renal and Pulmonary Late Effects of Cancer Therapy. Semin Oncol 2013;40(6):757-773. https://doi.org/10.1053/j.seminoncol.2013.09.009
Аксель Е.М., Матвеев В.Б. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология. 2019;15(2):15-24. https://doi.org/10.17650/1726-9776-2019-15-2-15-24
Сальников М.А., Пономарев А.В., Кельн А.А. Хирургическое лечение уротелиального рака верхних мочевых путей. Фундаментальная и клиническая онкология: достижения и перспективы развития. Российская научно-практическая конференция, посвящённая 40-летию НИИ онкологии Томского НИМЦ. 2019:196-198. eLIBRARY ID: 39266634
Павлов В.Н., Гилязова И.Р., Измайлов А.А., Климентова Е.А., Султанов И.Р., Бермишева М.А., Ахмадеев З.Р., Нургалиева А.Х., Ишбулатова Г.В., Хуснутдинова Э.К. Роль генов микроРНК участников VHL-HIF1a пути в развитии светлоклеточного рака почки. Вестник урологии. 2018;6(4):36-41. https://doi.org/10.21886/2308-6424-2018-6-4-36-41
Кельн А.А., Лыков А.В., Купчин А.В. Билатеральный почечно-клеточный рак. Тюменский медицинский журнал. 2015;4(1):46-48. eLIBRARY ID: 23867912
Шкодкин С.В., Идашкин Ю.Б., Фиронов С.А., Фентисов В.В., Удовенко А.Н. Открыта резекция почки при почечно-клеточном раке. Вестник урологии. 2018;6(2):54-61. https://doi.org/10.21886/2308-6424-2018-6-2-54-61
Зуков Р.А. Эпидемиологические особенности и факторы риска почечно-клеточного рака. Сибирское медицинское обозрение. 2013;5:15-19. eLIBRARY ID: 20466758
Пономарев А.В., Лыков А.В., Кельн А.А. Современные тенденции в развитии органосохраняющих операций при раке почки в Тюменской области. Академический журнал Западной Сибири. 2019;5:43-45. eLIBRARY ID: 41419106
Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60(1):39-44. https://doi.org/10.1016/j.eururo.2011.03.030
Keln A.A., Schmidt S.S., Kupchin A.V., Berdichevsky B.A. Active monitoring of contrast-accumulating kidney tumours. Urology Herald. 2020;8(4):53-61. (In Russ.) https://doi.org/10.21886/2308-6424-2020-8-4-53-61
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
